Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-064184

Director sold 1,560 shares at $17.82 ($27,799)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Myriam Curet Director 2020-12-15 Sale −1,560 $17.82 $27,799 19,240 D: show line 1 in the form
Open-market sales · 1,560 sh · avg $17.82 · $27,799
Loading xslF345X03/doc4.xml…